Sun Li-Chu, Chu Koung-Shing, Cheng Su-Chen, Lu Chien-Yu, Kuo Chao-Hung, Hsieh Jan-Sing, Shih Ying-Ling, Chang Shun-Jen, Wang Jaw-Yuan
Nutrition Service Team, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, ROC.
BMC Cancer. 2009 Aug 20;9:288. doi: 10.1186/1471-2407-9-288.
The aim of this study was to determine influence of prognostic factors in addition to UICC staging systems, on cancer-specific and overall survival rates for patients with colorectal cancer (CRC) undergoing surgical treatment.
Between January 1996 and December 2006, a total of 1367 CRC patients who underwent surgical treatment in Kaohsiung Medical University Hospital were analyzed. We retrospectively investigated clinicopathologic features of these patients. All patients were followed up intensively, and their outcomes were investigated completely.
Of 1367 CRC patients, there were seven hundred and fifty-seven males (55.4%) and 610 (44.6%) females. The median follow-up period was 60 months (range, 3-132 months). A multivariate analysis identified that low serum albumin level (P = 0.011), advanced UICC stage (P < 0.001), and high carcinoembryonic antigen (CEA) level (P < 0.001) were independent prognostic factors of cancer-specific survival. Meanwhile, a multivariate analysis showed age over 65 years (P < 0.001), advanced UICC stage (P < 0.001), and high CEA level (P < 0.001) were independent prognostic factors of overall survival. Furthermore, combination of UICC stage, serum CEA and albumin levels as predictors of cancer-specific survival showed that the poorer the prognostic factors involved, the poorer the cancer-specific survival rate. Likewise, combination of UICC stage, age and serum CEA level as predictors of overall survival showed that the poorer the prognostic factors involved, the poorer the overall survival rate. Of these prognostic factors, preoperative serum CEA level was the only significant prognostic factor for patients with stage II and III CRCs in both cancer-specific and overall survival categories.
Preoperative serum albumin level, CEA level and age could prominently affect postoperative outcome of CRC patients undergoing surgical treatment. In addition to conventional UICC staging system, it might be imperative to take these additional characteristics of factors into account in CRC patients prior to surgical treatment.
本研究旨在确定除UICC分期系统外,预后因素对接受手术治疗的结直肠癌(CRC)患者的癌症特异性生存率和总生存率的影响。
1996年1月至2006年12月期间,对高雄医学大学医院1367例接受手术治疗的CRC患者进行了分析。我们回顾性调查了这些患者的临床病理特征。对所有患者进行了密集随访,并全面调查了他们的预后情况。
1367例CRC患者中,男性757例(55.4%),女性610例(44.6%)。中位随访期为60个月(范围3 - 132个月)。多因素分析确定低血清白蛋白水平(P = 0.011)、UICC晚期(P < 0.001)和高癌胚抗原(CEA)水平(P < 0.001)是癌症特异性生存的独立预后因素。同时,多因素分析显示年龄超过65岁(P < 0.001)、UICC晚期(P < 0.001)和高CEA水平(P < 0.001)是总生存的独立预后因素。此外,将UICC分期、血清CEA和白蛋白水平联合作为癌症特异性生存的预测指标显示,所涉及的预后因素越差,癌症特异性生存率越低。同样,将UICC分期、年龄和血清CEA水平联合作为总生存的预测指标显示,所涉及的预后因素越差,总生存率越低。在这些预后因素中,术前血清CEA水平是II期和III期CRC患者在癌症特异性生存和总生存类别中唯一显著的预后因素。
术前血清白蛋白水平、CEA水平和年龄可显著影响接受手术治疗的CRC患者的术后结局。除了传统的UICC分期系统外,在CRC患者手术治疗前考虑这些额外的因素特征可能势在必行。